Enzyme Based Approaches in Cancer Healthcare Management
暫譯: 基於酶的癌症健康管理方法

Dr. Dalapathi Gugulothu completed his PhD and M.Pharm from the Institute of Chemical Technology, Mumbai, India and earned his B.Pharm from Kakatiya University, Warangal, Telangana, India. He is currently serving at the Delhi Institute of Pharmaceutical Sciences and Research, part of the Delhi Pharmaceutical Sciences and Research University, New Delhi. His research focuses on a variety of advanced topics, including siRNA delivery, nanotoxicology, targeted drug delivery systems, nanofibers, exosomes, gastroretentive drug delivery systems, orodispersible drug delivery systems and lyophilization cycle development. He has presented numerous research papers at national and international conferences, earning multiple awards for his work. He Gugulothu has been granted three Indian patents and has authored numerous research & review articles, as well as six book chapters. Additionally, he has successfully completed a research project funded by the Science and Engineering Research Board, Department of Science & Technology and recently working on another research project funded by SERB-DST. He has also been awarded travel grants from DBT & DST to attend conferences, reflecting his active engagement and contributions to the field of pharmaceutical sciences.

Dr. Sushama Talegaonkar is working in the Department of Pharmaceutics, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences & Research University (DPSRU), New Delhi. With over 24 years of teaching and research experience, she has been recognized among the top two percent of world scientists in the global list compiled by Stanford University for five consecutive years: 2020, 2021, 2022, 2023, 2024. She holds three Indian patents and has filed six others. She has published over 220 research papers in high-impact international journals and 30 in national journals, with an h-index of 59, an i10-index of 160 and more than 14,000 Google Scholar citations. She has co-authored six books and contributed 30 chapters to international reference volumes. Her accolades include the "Prof C J Shishoo Award" by APTI, the "UGC Research Award" (2014-2016) and the prestigious Motan Devi Dandiya Biennial Prize for best publication in Pharmaceutical Sciences for the period 2010-11, among others. Her research focuses on developing a wide variety of smart and functionalized nano drug delivery systems for targeted anticancer drug delivery. She has completed research projects amounting to more than rupees one crore, funded by prominent agencies such as UGC, AICTE, DBT and SERB.

Dr. Lalit Kumar is currently working in the Department of Pharmaceutics at the National Institute of Pharmaceutical Education & Research, Hajipur, Bihar, India. He completed his PhD in nanoparticulate drug delivery systems and has made significant contributions to pharmaceutical research. He has authored around 150 peer-reviewed journal articles, over 35 book chapters, 2 books and holds 3 granted Indian patents, with 8 more applications under review. His research focuses on developing nanocarriers for targeted drug delivery to tumors, the colon, the brain, the breast and the lungs. He has successfully completed over ten research projects, collectively funded with more than ₹1.5 crore by agencies such as All India Council of Technical Education, New Delhi; the Karnataka State Government Vision Group of Science & Technology, Bengaluru; the Science & Engineering Research Board (SERB), New Delhi; and the Indian Council of Medical Research, New Delhi. His work has been recognized with several awards, including the Prof. M.L Khorana Memorial Prize in 2018 and the Dr. T.M.A. Pai Gold Medal in 2019 and 2023. He has been named among the top 2% of world scientists by Stanford University in 2023, 2024 & 2025. He is also a life member of six scientific organizations. As a reviewer for more than 80 peer-reviewed journals, he received Publon's Top 1% Reviewer Award (2017-2019) under the "Pharmacy, Pharmacology and Toxicology" category.

達拉帕提·古古洛圖博士於印度孟買的化學技術學院完成其博士學位及藥學碩士學位，並在印度特倫甘納邦的卡卡提亞大學獲得藥學學士學位。他目前在新德里的德里藥學科學與研究學院（Delhi Institute of Pharmaceutical Sciences and Research）任職，該學院隸屬於德里藥學科學與研究大學（Delhi Pharmaceutical Sciences and Research University）。他的研究專注於多種先進主題，包括siRNA傳遞、納米毒理學、靶向藥物傳遞系統、納米纖維、外泌體、胃滯留藥物傳遞系統、口溶性藥物傳遞系統及冷凍乾燥循環開發。他在國內外會議上發表了多篇研究論文，並因其工作獲得多項獎項。古古洛圖博士已獲得三項印度專利，並撰寫了多篇研究與綜述文章，以及六個書章。此外，他成功完成了一項由科學與工程研究委員會（Science and Engineering Research Board）資助的研究項目，並最近正在進行另一項由SERB-DST資助的研究項目。他還獲得了來自DBT和DST的旅行補助，以參加會議，反映出他在藥學領域的積極參與和貢獻。

蘇莎瑪·塔雷戈卡博士目前在新德里的德里藥學科學與研究大學（Delhi Pharmaceutical Sciences & Research University, DPSRU）藥劑學系工作。擁有超過24年的教學和研究經驗，她在史丹佛大學編制的全球科學家名單中連續五年（2020、2021、2022、2023、2024）被認定為全球前2%的科學家。她擁有三項印度專利，並已申請六項其他專利。她在高影響力的國際期刊上發表了超過220篇研究論文，在國內期刊上發表了30篇，擁有59的h指數、160的i10指數以及超過14,000次的Google Scholar引用。她共同撰寫了六本書籍，並為國際參考書籍貢獻了30個章節。她的榮譽包括由APTI頒發的「C J Shishoo教授獎」、UGC研究獎（2014-2016）以及2010-11年度藥學最佳出版物的著名Motan Devi Dandiya雙年獎等。她的研究專注於開發各種智能和功能化的納米藥物傳遞系統，以實現靶向抗癌藥物的傳遞。她已完成的研究項目資金超過一億印度盧比，資助機構包括UGC、AICTE、DBT和SERB等。

拉利特·庫馬博士目前在印度比哈爾邦哈吉普爾的國立藥學教育與研究所（National Institute of Pharmaceutical Education & Research）藥劑學系工作。他在納米顆粒藥物傳遞系統方面獲得博士學位，並對藥學研究做出了重要貢獻。他已撰寫約150篇經過同行評審的期刊文章、超過35個書章、2本書籍，並擁有3項已授予的印度專利，另有8項申請正在審核中。他的研究專注於開發納米載體，以實現對腫瘤、結腸、大腦、乳腺和肺部的靶向藥物傳遞。他成功完成了超過十個研究項目，總資金超過1.5億印度盧比，資助機構包括新德里的全印度技術教育委員會、班加羅爾的卡納塔克邦政府科學與技術願景小組、新德里的科學與工程研究委員會（SERB）以及新德里的印度醫學研究委員會等。他的工作獲得了多項獎項，包括2018年的M.L Khorana紀念獎和2019及2023年的T.M.A. Pai金獎。他在2023、2024和2025年被史丹佛大學評選為全球前2%的科學家。他還是六個科學組織的終身會員。作為超過80本同行評審期刊的審稿人，他在「藥學、藥理學和毒理學」類別中獲得了Publon的前1%審稿人獎（2017-2019）。